RxDoctor Payments Data

Michelle Helton, DO

Family Medicine · Camdenton, MONPI 1194257378

Payments from drug & device makers

$439in general payments, 2019–2025

Across 22 payments — averaging $19.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$151
  • Pfizer$47
  • Collegium Pharmaceutical, Inc.$45
  • GSK$31
  • Viatris Specialty LLC$29
  • Abbott$25
  • plus $112 from 7 others

What the payments were for

  • Food & beverage$439100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$439 in reported general payments places this provider in the 50th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$7,768
Medicare patients
63
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban106$125,039
JardianceEmpagliflozin74$77,529
MounjaroTirzepatide30$51,705
JanuviaSitagliptin Phosphate29$35,119
TradjentaLinagliptin37$27,629
OzempicSemaglutide20$24,528
ArexvyRsvpref3 Antigen/As01e/Pf71$18,636
TrulicityDulaglutide11$14,531
Breo ElliptaFluticasone/Vilanterol17$10,655
Spiriva RespimatTiotropium Bromide18$9,309
SymbicortBudesonide/Formoterol Fumarate31$8,602
Advair HfaFluticasone Propion/Salmeterol23$8,138
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$4,274
Atorvastatin Calcium521$3,436
AbrysvoRsv Vacc, Pref A And Pref B/Pf11$3,380

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$47$128,419117 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$16$114,467129 claims
GSKArexvy, Breo Ellipta$31$29,29088 claims
AstraZenecaSymbicort$14$8,60231 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Camdenton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →